Retraction-Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial

Affiliations

The Lancet Editors. Lancet. 2019.

. 2019 Mar 16;393(10176):1084.

doi: 10.1016/S0140-6736(19)30542-2. Epub 2019 Mar 14.

No abstract available

Retraction of

Retracted: Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial.
Bolli R, Chugh AR, D'Amario D, Loughran JH, Stoddard MF, Ikram S, Beache GM, Wagner SG, Leri A, Hosoda T, Sanada F, Elmore JB, Goichberg P, Cappetta D, Solankhi NK, Fahsah I, Rokosh DG, Slaughter MS, Kajstura J, Anversa P. Bolli R, et al. Lancet. 2011 Nov 26;378(9806):1847-57. doi: 10.1016/S0140-6736(11)61590-0. Epub 2011 Nov 14. Lancet. 2011. Retraction in: Lancet. 2019 Mar 16;393(10176):1084. doi: 10.1016/S0140-6736(19)30542-2. PMID: 22088800 Free PMC article. Retracted. Clinical Trial.

1. The Lancet Editors. Expression of concern: the SCIPIO trial. Lancet 2014; 383: 1279. - PMC - PubMed
1. Bolli R, Chugh AR, D’Amario D, et al. Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial. Lancet 2011; 378: 1847–57. - PMC - PubMed